Arachidonic acid 5-lipoxygenase (ALOX5) is the key enzyme in the biosynthesis of pro-inflammatory leukotrienes. We recently created knock-in mice (-KI) which express an arachidonic acid 15-lipoxygenating Alox5 mutant instead of the 5-lipoxygenating wildtype enzyme. These mice were leukotriene deficient but exhibited an elevated linoleic acid oxygenase activity.
View Article and Find Full Text PDFObjective: Cyclooxygenase (COX)-derived prostaglandin E (PGE) is an important lipid mediator in colorectal carcinoma (CRC) pathogenesis. Other lipid mediators derived from lipoxygenases (LOX) have also been implicated in neoplastic processes in the colon. In this study we aimed to characterize lipid mediators, so called oxylipins, in human colon adenomatous polyps.
View Article and Find Full Text PDFBiochim Biophys Acta Mol Cell Biol Lipids
December 2020
Biochim Biophys Acta Mol Cell Biol Lipids
September 2020
Prostaglandins Other Lipid Mediat
February 2020
Lipoprotein apheresis reliably reduces low-density lipoprotein (LDL) cholesterol in patients with atherosclerotic disease and therapy-refractory hypercholesterolemia or elevated lipoprotein (a) (Lp(a)). Besides lowering lipoproteins and triglycerides, apheresis also decreases levels of essential omega-6 and omega-3 polyunsaturated fatty acids (6 and 3 PUFAs) in blood plasma. In contrast, heparin-induced extracorporeal low-density lipoprotein precipitation (HELP) lipid apheresis might increase the formation of potentially pro-inflammatory and pro-thrombotic lipid mediators derived from 6 and 3 PUFAs.
View Article and Find Full Text PDFProstaglandins Other Lipid Mediat
November 2017
Biochim Biophys Acta Mol Cell Biol Lipids
July 2017
Prostaglandins Leukot Essent Fatty Acids
December 2016